Doug Cole

Managing Partner at Flagship Pioneering

Doug Cole

Doug Cole

Managing Partner at Flagship Pioneering

Overview

Career Highlights

Flagship Pioneering
Inzen Therapeutics
Modernatx, Inc.

RelSci Relationships

3164

Number of Boards

35

Birthday

1960

Age

61

Relationships

View Relationship Details

RelSci Relationships are individuals Doug Cole likely has professional access to. A relationship does not necessarily indicate a personal connection.

Robert Langer

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Noubar Afeyan

Co-Founder at Moderna, Inc.

Relationship likelihood: Strong

Stéphane Bancel

Director & Chief Executive Officer at Moderna, Inc.

Relationship likelihood: Strong

Robert Nelsen

Co-Founder at Vir Biotechnology, Inc.

Relationship likelihood: Strong

Rich Aldrich

Chairman of the Board, Co-Founder at Concert Pharmaceuticals, Inc.

Relationship likelihood: Strong

Peter Barton Hutt

Professor at Harvard University

Relationship likelihood: Strong

David Berry

President at Epiva Biosciences, Inc.

Relationship likelihood: Strong

Bart Henderson

Co-Founder at Torque Therapeutics, Inc.

Relationship likelihood: Strong

Amir Nashat

Partner at Polaris Partners

Relationship likelihood: Strong

John D. Mendlein

Founder at Fate Therapeutics, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

RelSci

January 13, 2021

Doug Cole is no longer serving in their position at Inzen Therapeutics

PR Newswire

January 13, 2021

Flagship Pioneering Unveils Inzen Therapeutics; Company developing new class of transformative medicines based on Thanokine Biology

The Boston Globe

October 24, 2020

Foghorn raises $120m in its IPO; The Cambridge biotech is working on a system to regulate genes to treat cancer.

GlobeNewswire

October 23, 2020

Foghorn Therapeutics Announces Pricing of Initial Public Offering

Business Wire

July 8, 2020

Foghorn® Therapeutics Announces Collaboration with Merck to Discover and Develop Novel Oncology Therapeutics Against Transcription Factor Target

Paths to Doug Cole

Potential Connections via
Relationship Science

You

Doug Cole

Managing Partner at Flagship Pioneering

Education

MD

Class of 1986

University of Pennsylvania - Perelman School of Medicine

The University of Pennsylvania is the oldest and one of the finest medical schools in the United States. Penn is rich in tradition and heritage and at the same time consistently at the forefront of new developments and innovations in medical education and research. Since its founding in 1765 the School has been a strong presence in the community and prides itself on educating the leaders of tomorrow in patient care, biomedical research, and medical education. At Penn academic excellence, as well as compassion for the patients we are privileged to serve, are stressed. Skillful compassion is truly a hallmark of the Penn learning experience. The Perelman School of Medicine at the University of Pennsylvania consistently ranks among the top five in US News and World Report’s rankings of research-oriented medical schools.

AB

Class of 1982

Dartmouth College

Founded in 1769, Dartmouth is a member of the Ivy League and consistently ranks among the world's greatest academic institutions. Dartmouth has forged a singular identity for combining its deep commitment to outstanding undergraduate liberal arts and graduate education with distinguished research and scholarship in the Arts & Sciences and its three leading professional schools—the Geisel School of Medicine, Thayer School of Engineering, and the Tuck School of Business.

Memberships

Member

Current

Alpha Omega Alpha Honor Medical Society

Alpha Omega Alpha supports many programs for medical students and physicians at our 123 chapters, and publishes a quarterly journal, The Pharos, which contains articles on nontechnical medical subjects, including history, ethics, national issues, personal essays, and poetry.

Career History

Professional

Prior

Hypnion, Inc.

Hypnion, Inc. discovered and developed neuroscience drugs. It focused on the development of novel therapeutics for the treatment of central nervous system disorders to serve the underserved markets of sleep and wake-alertness disorders and circadian rhythm abnormalities. The company was founded in 2000 and was headquartered in Lexington, MA.

Managing Partner

2001 - Current

Flagship Pioneering

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Co-Founder

2004 - Prior

Ensemble Therapeutics Corp.

Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA.

Boards & Committees

Member, Board of Directors

2015 - Current

Foghorn Therapeutics, Inc.

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Director

2015 - Current

Torque Therapeutics, Inc.

Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA.

Chairman, Board of Directors

2015 - Current

Sigilon Therapeutics, Inc.

Sigilon Therapeutics, Inc. engages in the research and development of therapeutic treatments for a wide range of chronic diseases. The company was founded by Daniel G. Anderson, Robert S. Langer Jr., Jose Oberholzer, Arturo Vegas, and Omid Veiseh on May 14, 2015 and is headquartered in Cambridge, MA.

Member, Board of Directors

Current

Spinal Muscular Atrophy Foundation

The mission of the Spinal Muscular Atrophy Foundation is to accelerate the development of a treatment for SMA, the number one genetic killer of infants and toddlers.

Member, Board of Directors

Prior

Birch Rock Camp

TRADITIONAL SUMMER CAMP FOR BOYS AGES 7 - 15

Member, Genetics Advisory Council

Tenure Unconfirmed

Harvard Partners Center for Genetics & Genomics

Political Donations

$500

2002

Mitt Romney

Senator at Office of the Senator from Utah, Mitt Romney

$200

2002

Christopher F. O. Gabrieli

Co-Founder at Empower Schools

Investments

Details Hidden

Foghorn Therapeutics, Inc.

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Details Hidden

Ensemble Therapeutics Corp.

Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA.

Details Hidden

Permeon Biologics, Inc.

Permeon Biologics, Inc. develops intracellular biotherapeutics platform to enhance drug delivery. Its intraphilin technology platform leverages research on remodeling the surfaces of proteins to permit cell penetration without losing their structure or activity; and enables functional proteins to replace or restore defective pathways inside cells that cause disease. The company was founded by Douglas G. Cole, David R. Liu, John W. Ripple, and Noubar B. Afeyan in 2008 and is headquartered in Cambridge, MA.

Other Affiliations

Doug Cole is affiliated with Hypnion, Inc., Flagship Pioneering, Ensemble Therapeutics Corp., Vertex Pharmaceuticals, Inc., Harvard University - Harvard Medical School, The Johns Hopkins Hospital, Inc., Permeon Biologics, Inc., Modernatx, Inc., The Massachusetts General Hospital, Gilead Sciences, Inc., Inzen Therapeutics, Foghorn Therapeutics, Inc., Torque Therapeutics, Inc., Sigilon Therapeutics, Inc., Denali Therapeutics, Inc., Sana Biotechnology, Inc., TARIS BioMedical LLC, Modernatx, Inc., Concert Pharmaceuticals, Inc., Editas Medicine, Inc., Receptos LLC, Agios Pharmaceuticals, Inc., Quanterix Corp., Zalicus, Inc., Tetraphase Pharmaceuticals, Inc., Ensemble Therapeutics Corp., EPIRUS Biopharmaceuticals, Inc., AVEO Pharmaceuticals Inc., Avedro, Inc., Moderna, Inc., Seventh Sense Biosystems, Inc., Morphotek, Inc., KSQ Therapeutics, Inc., Selecta Biosciences, Inc., Gilead Connecticut, Inc., CombinatoRx, Inc., Syros Pharmaceuticals, Inc., Alvine Pharmaceuticals, Inc., Apoptos, Inc., Permeon Biologics, Inc., Resolvyx Pharmaceuticals, Inc., Massachusetts Life Sciences Center, Gilead Sciences, Inc., Spinal Muscular Atrophy Foundation, Birch Rock Camp, Harvard Partners Center for Genetics & Genomics

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Doug Cole. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Doug Cole's profile does not indicate a business or promotional relationship of any kind between RelSci and Doug Cole.